Biosimilar Adalimumab, Etanercept Have Equivalent Effectiven

The levels of disease activity after 6 months of tumor necrosis factor-α inhibitors could help predict the response to therapy at 4 years for those who have long-standing rheumatoid arthritis.

Related Keywords

Humira Abbvie , Samsing Biopis , Enbrel Amgen , Novartis , Clinical Drug , Joint Disease Activity Score , Simplified Disease Activity Index , Clinical Disease Activity Index ,